Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 320-325

  Alonso Galicia, Magdalena ^a   Drummond, Heather A ^a   Kishta Reddy, K ^b   Falck, John R ^b   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

enzymes; nitric oxide; vasculature

Indexed keywords

CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPIONAMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY METABOLISM; KIDNEY MICROSOME; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0031017358     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.320     Document Type: Article

References (23)

1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KM. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
2. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
3. Bachman S, Mundel P. Nitric oxide in the kidney: synthesis, localization and function. Am J Kidney Dis. 1994;24:112-129.
4. Cohen RA. The role of nitric oxide and other endothelial derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995;38:105-128.
5. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation. 1995;92: 3337-3349.
6. Bolontina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
7. Hurshman AR, Marietta MA. Nitric oxide complexes of inducible nitric oxide synthase: spectral characterization and effects on catalytic activity. Biochemistry. 1995;34:5627-5634.
8. Griscavage JM, Habbs AJ, Ignarro LJ. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol. 1995;34:215-234.
9. Wink DA, Osawa Y, Darbyshine JF, Jones CR, Eshenaus SC, Nims RW. Inhibition of cytochrome P450 by nitric oxide and a nitric oxide releasing agent. Arch Biochem Biophys. 1993;300:115-123.
10. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA. 1993; 90:11147-11151.
11. Duthu GS, Schertze HG. Effect of nitrate on rabbit liver mixed functional oxidase activity. Drug Metab Dispos. 1979;7:263-269.
12. Schertze HG, Duthu GS. Nitrate binding to rabbit liver microsomes and effects of aminopyridine demethylation. Biochem Pharmacol. 1979;28:873-879.
13. Harder DR, Gebremedhin D, Narayanant J, Jefcoat C, Falck JR, Campbell WB, Roman RJ. Formation and action of a P4504A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol. 1994;266:H1840-H1845.
14. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and action of 20-HETE on rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
15. Imig JD, Zou AP, Ortiz de Montellano PR, Sui Z, Roman RJ. Cytochrome P450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am J Physiol. 1994;266:H1879-H1885.
16. Zou AP, Imig J, Kaldunski M, Ortiz de Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular production of 20-hydroxyeicosatetraenoic acid impairs autoregulation of renal blood flow. Am J Physiol. 1994;266:F275-F282.
17. Zou AP, Imig J, Ortiz de Montellano PR, Sui Z, Falck JR, Roman RJ. Endogenous P450 metabolites of arachidonic acid modulate tubuloglomerular feedback. Am J Physiol. 1994;267:F934-F941.
18. Ma YH, Schwartzman ML, Roman RJ. Renal metabolism of arachidonic acid in Dahl rats. Am J Physiol. 1994;267:R579-R589.
19. Ma YH, Gebremedhin D, Schwartzman ML, Clark JE, Harder DR, Masters BSS, Roman RJ. 20-HETE is an endogenous vasoconstrictor of dog renal arcuate arteries. Circ Res. 1993;72:126-136.
20. Zou AP, Ma YH, Ortiz de Montellano PR, Clark JE, Masters BS, Roman RJ. Effects of 17-ODYA, a suicide-substrate inhibitor of P450 fatty acid ω-hydroxylation on renal function in rats. J Pharmacol Exp Ther. 1994;268:474-481.
21. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, Roman RJ. 20-hydroxyeicosatetraenoic acid is an endogenous inhibitor of the large conductance Ca++-activated K+-channel in renal arterioles. Am J Physiol. 1996;270:R228-R237.
22. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P450 enzymes in the control of vascular tone. J Vasc Res. 1995;32:79-92.
23. Brand-Schieber E, Takizawa H, Falck JR, Laniado-Schwartzman M, Nasjletti A. Increased dietary salt attenuates a renal vasoconstrictor mechanism mediated by 20-HETE. Hypertension. 1996;28:542. Abstract.